Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study

• Main Authors: Wenxin Hong (Author), Yan Chen (Author), Kai You (Author), Shenglin Tan (Author), Feima Wu (Author), Jiawang Tao (Author), Xudan Chen (Author), Jiaye Zhang (Author), Yue Xiong (Author), Fang Yuan (Author), Zhen Yang (Author), Tingting Chen (Author), Xinwen Chen (Author), Ping Peng (Author), Qiang Tai (Author), Jian Wang (Author), Fuchun Zhang (Author), Yin-Xiong Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The pandemic of coronavirus disease 2019 (COVID-19) resulted in grave morbidity and mortality worldwide. There is currently no effective drug to cure COVID-19. Based on analyses of available data, we deduced that excessive prostaglandin E2 (PGE2) produced by cyclooxygenase-2 was a key pa...